Eligible medicare beneficiaries at participating healthcare providers will soon be able to purchase $500 worth of hemp-derived products annually for medical purposes.
Under a new Centers for Medicare and Medicaid Services pilot program that begins on Wednesday, participating healthcare providers can offer their eligible patients hemp-derived CBD and THC products for symptom control with no out-of-pocket cost to the patient.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
